Evidence map›Paper›PMID 41201866›Full record

ReviewKidney3602026

Troubleshooting Ionized Hypocalcemia in Patients on Continuous KRT with Regional Citrate Anticoagulation.

Lenar Yessayan, Ashita Tolwani, Michael Heung, Balazs Szamosfalvi

Abstract readReview
In one paragraph

Review in Kidney360, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lenar YessayanDivision of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-8955-1292
Ashita TolwaniDivision of Nephrology, Department of Internal Medicine, University of Alabama at Birmingham, Birmingham, Alabama.ORCID 0000-0002-2445-0386
Michael HeungDivision of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-0533-3192
Balazs SzamosfalviDivision of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-9519-0411

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regional citrate anticoagulation (RCA) is the preferred anticoagulation method in continuous KRT (CKRT), provided its use is feasible without causing excessive systemic citrate accumulation. One significant concern with RCA is ionized hypocalcemia related to the CKRT procedure. This condition can arise from two primary causes: systemic citrate accumulation or net calcium loss from plasma. Systemic citrate accumulation occurs when the citrate load in the CKRT return blood exceeds the body's ability to metabolize it. On the other hand, net calcium loss occurs when calcium lost through the hemofilter and from the extracellular fluid space (due to tissue sequestration) exceeds the administered calcium supplementation. This case-based review outlines RCA-associated hypocalcemia and provides a framework for its evaluation and management at the bedside.

Indexed as

AnticoagulantsCalciumCitric AcidContinuous Renal Replacement TherapyHypocalcemiaCase Reports as TopicHumansAnticoagulantsCalciumCitric Acidcalciumclinical nephrologyelectrolytesKRTrenal replacement therapy

Identifiers

PMID41201866
PMCPMC13229442

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.